產(chǎn)品編號(hào) | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購(gòu)物車 | |
---|---|---|---|---|---|
![]() |
Canertinib dihydrochloride,98% | C24H27Cl3FN5O3 | |||
|
|||||
![]() |
TCS 359,99% | C18H20N2O4S | |||
|
|||||
![]() |
SB431542,98% | C22H16N4O3 | |||
|
|||||
![]() |
ZM 447439,98% | C29H31N5O4 | |||
|
|||||
![]() |
Telatinib,98% | C20H16ClN5O3 | |||
|
|||||
![]() |
CP-673451,≥98% | C24H27N5O2 | |||
|
|||||
![]() |
N-Desethyl Sunitinib,95% | C20H23FN4O2 | |||
|
|||||
![]() |
SB525334,99% | C21H21N5 | |||
|
|||||
![]() |
Tandutinib (MLN518),99% | C31H42N6O4 | |||
|
|||||
![]() |
PHA-680632,98% | C28H35N7O2 | |||
|
|||||
![]() |
CHIR-124,98% | C23H22ClN5O | |||
|
|||||
![]() |
Dovitinib (TKI-258, CHIR-258),99% | C21H21FN6O | |||
|
|||||
![]() |
RepSox,99% | C17H13N5 | |||
|
|||||
![]() |
BMS-536924,98% | C25H26ClN5O3 | |||
|
|||||
![]() |
NVP-AEW541,≥98% | C27H29N5O | |||
|
|||||
![]() |
PHA-665752,96% | C32H34Cl2N4O4S | |||
|
|||||
![]() |
AEE788 (NVP-AEE788),98% | C27H32N6 | |||
|
|||||
![]() |
Terfenadine,98% | C32H41NO2 | |||
|
|||||
![]() |
Icotinib,98% | ? C22H21N3O4 | |||
|
|||||
![]() |
Oltipraz,99% | C8H6N2S3 | |||
|
|||||
![]() |
BAY 61-3606 (dihydrochloride),98% | C20H20Cl2N6O3 | |||
|
|||||
![]() |
SU11274,98% | C28H30CIN5O4S | |||
|